Danone ECONOMIC

Supply Chain & Sourcing Relationships

Danone’s 2025 subsidiary schedule lists Strauss Health Ltd as an Israel-domiciled equity-company investment held at 20.00%, rather than as a Danone-controlled subsidiary ¹.

Danone’s 2022 subsidiary schedule also listed Strauss Health Ltd in Israel at 20.00%, indicating that the disclosed minority interest existed by 2022 and remained listed in the 2025 schedule ^{1, 2}.

A March 2004 report stated that Danone would not permit sales of its products in Israel outside its Strauss partnership, reported Danone’s then-20% holding in Strauss Dairies, and identified Actimel as an example product; this historical report does not establish the present commercial terms or activity of that relationship ³.

Israel’s food-importer registration framework requires an importer of non-animal-based food to be an Israeli-registered company, corporation, or licensed dealer, and records the importer and warehouse details ⁴.

No public evidence identified of a Danone-specific importer-registration record, supplier contract, seasonal procurement programme, white-label arrangement, or customer relationship involving Mehadrin, Hadiklaim, Galilee Export, or an Agrexco successor.

The reviewed Mehadrin and Hadiklaim corporate materials did not identify Danone as a customer, partner, or importer ^{5, 6}.

Product Origin, Labeling & Regulatory Compliance

No public evidence identified of a Danone-specific public regulatory citation, customs or DEFRA audit, NGO investigation, or enforcement action concerning settlement-origin products labelled as Israeli produce.

No public evidence identified of a Danone corporate policy specifically addressing sourcing from, sales in, or labelling of goods from the West Bank, East Jerusalem, or the Golan Heights.

The available evidence identifies a historical Strauss relationship and current Danone-brand web routing, but does not identify the origin, importer of record, manufacturing site, or labelling treatment of particular Danone-branded products sold in Israel ^{3, 7, 8}.

Investment, Capital & Financial Exposure

Danone’s 2014 registration document included Strauss Health Ltd in Israel in its appendix headed “List of subsidiaries,” although the relevant page did not state the percentage held, acquisition price or date, manufacturing location, workforce, or control status ⁹.

Danone’s 2025 subsidiary schedule provides the more recent disclosure that Strauss Health Ltd is a 20.00% equity-company investment ¹.

A 17 May 2023 Wilk Technologies regulatory disclosure identified Danone Manifesto Ventures Europe SAS as an interested holder and stated that it was wholly owned by Dan Investments SAS, with both entities incorporated in France ¹⁰.

Wilk stated in a 25 June 2023 filing that it entered a non-binding memorandum of understanding with Nutricia Research B.V. on 22 June 2023 for a proposed two-year joint-development arrangement concerning cell-based lipids, their potential use, and regulatory pathway ¹¹.

Wilk’s filing stated that the proposed arrangement remained subject to further discussions, could be terminated, and offered no certainty that a binding agreement would be concluded ¹¹.

The reviewed filings do not establish Danone’s current Wilk holding, whether a binding joint-development agreement was executed, or whether the proposed collaboration remained active after its contemplated period ^{10, 11}.

A 2006 Tel Aviv Stock Exchange filing described Danone Springs of Eden BV as a Netherlands-incorporated company owned through subsidiaries of Groupe Danone and Eden Springs Ltd, Israel, while describing its operating activity as European home-and-office mineral-water extraction, bottling, marketing, and distribution rather than an Israeli operating facility ¹².

No public evidence identified of a Danone-owned Israeli factory, R&D centre, data centre, logistics hub, Israeli sovereign-bond holding, Israel-focused fund holding, or investment in occupied territory.

Operational Presence & Market Activity

Danone’s current country-websites directory includes an “Israel” entry labelled “Danone” that routes to Strauss Group’s Danone-brand page ^{7, 8}.

The directory routing and brand page evidence web presentation of the Danone brand in Israel, but do not by themselves establish Danone’s ownership percentage, local office, manufacturing, importer-of-record status, revenue, workforce, or operations at a particular location ^{7, 8}.

No public evidence identified of Danone-operated offices, warehouses, retail locations, workforce size, tax registration, or market-specific revenue in Israel or occupied territory.

No public evidence identified in the reviewed corporate records of operations in the West Bank, East Jerusalem, the Golan Heights, or other occupied territories.

Corporate Structure & Foundational Ties

Danone S.A. is a French corporation registered in the Paris trade register under number 552.032.534, with its registered office at 59–61 rue La Fayette, 75009 Paris, France ¹³.

Danone’s 2025 Universal Registration Document identifies BlackRock, Artisan Partners, and Capital Group among the reported major shareholders as of 31 December 2025, and does not identify a controlling shareholder or Israeli beneficial owner ¹⁴.

Danone’s governance page identifies Gilles Schnepp as Chair of the Board and Antoine de Saint-Affrique as Chief Executive Officer, alongside the company’s listed directors and Executive Committee ¹⁵.

Danone’s 2014 registration document identified Danone S.A. as the parent company of the Danone Group and described its role as holding group companies and coordinating group functions ⁹.

No public evidence identified that Danone was founded in Israel, is Israeli-headquartered, holds Israeli Preferred Technology Enterprise status, is Israeli tax-resident, or is controlled by Israeli capital.

No public evidence identified in the reviewed corporate records of Israeli state ownership, government board appointments, a golden-share arrangement, critical-infrastructure designation, or governance mechanisms structurally tying Danone to Israeli state policy.

The supplied document-scoped review reported no Danone mention in the specified UN Special Rapporteur report and OHCHR settlement-business database update; this result is limited to those reviewed documents and does not establish database-wide absence ^{16, 17}.

Profit Repatriation & Economic Contribution

No public evidence identified of Danone-disclosed Israel-attributable revenue, Israeli tax contribution, profit-repatriation amount, or Israeli-government or industry designation of Danone as a sector anchor or critical employer.

The 2006 Danone Springs of Eden filing identifies an Israeli co-owner but describes European operating activities, and is therefore insufficient to establish profit flows into or out of Israel ¹².

Danone’s disclosed 20.00% equity investment in Strauss Health Ltd establishes a minority investment relationship, but the reviewed schedules do not disclose its investment amount, earnings contribution, dividend flows, tax payments, manufacturing sites, or employment footprint ^{1, 2}.

Supplementary current commercial disclosures

Strauss’s FY2025 report describes manufacture and marketing in Israel of Danone-branded products and Alpro plant-based products, including joint Alpro-Strauss branding ¹⁸.

It reports approximately NIS 39 million, NIS 37 million, and NIS 34 million in licence, know-how, and royalty costs under the Danone agreement for 2025, 2024, and 2023 respectively ¹⁸. These are agreement-related costs, not Danone’s total Israel revenue or tax contribution ¹⁸.

The report also describes the June 2021 plant-based licence as covering Israel, the Golan Heights, East Jerusalem, the West Bank, and Gaza, with exports outside the territory requiring Danone’s advance approval ¹⁸. The contractual territory does not establish a transaction at a named settlement or a Danone-controlled facility ¹⁸.